Review Article
A Meta-Analysis of 13 Randomized Trials on Traditional Chinese Medicine as Adjunctive Therapy for COVID-19: Novel Insights into Lianhua Qingwen
Table 3
The outcomes of this meta-analysis.
| | Outcomes | Studies Numbers | Sample size | Overall effect | Heterogeneity | | Experiment | Control | Effect estimates | 95% CIs | value | (%) | value |
| | Traditional Chinese medicine as the adjunctive therapy for COVID-19 | | Total effective | 8 | 484/569 | 347/549 | | 1.259-1.464 | | 74.8% | | | Improvement of chest CT | 6 | 333/431 | 268/433 | | 1.143-1.356 | | 0.0% | | | Fever improvement | 3 | 127/141 | 78/99 | | -0.063-0.283 | | 84.1% | | | Cough improvement | 3 | 99/137 | 60/103 | | 1.057-1.570 | | 0.0% | | | Conversion to severe cases | 5 | 30 of 480 | 72 of 460 | | 0.275-0.605 | | 9% | | | The subgroup of Lianhua Qingwen as the adjunctive therapy for COVID-19 | | Total effective | 3 | 264/324 | 216/331 | | 1.136-1.371 | | 0.0% | | | Improvement of chest CT | 3 | 252/324 | 210/331 | | 1.110-1.356 | | 34.3% | | | Conversion to severe cases | 4 | 29/410 | 63/417 | | 0.311-0.707 | | 0.0% | |
|
|
Note: CIs = confidence intervals; RD = rate difference; OR = odds ratio.
|
